Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.03 $5.78 Friday, 10th May 2024 BCRX stock ended at $5.32. This is 0.375% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $5.23 to a day high of $5.78.
90 days $4.03 $6.35
52 weeks $4.03 $8.96

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Mar 10, 2020 $3.62 $3.63 $2.66 $2.81 8 980 678
Mar 09, 2020 $4.28 $4.35 $3.05 $3.15 12 106 986
Mar 06, 2020 $3.76 $4.25 $3.70 $4.11 15 242 951
Mar 05, 2020 $3.79 $4.22 $3.56 $3.83 20 707 831
Mar 04, 2020 $3.22 $3.70 $3.18 $3.51 10 698 894
Mar 03, 2020 $3.24 $3.27 $2.94 $3.14 6 150 081
Mar 02, 2020 $3.10 $3.33 $2.95 $3.26 10 839 566
Feb 28, 2020 $2.96 $3.14 $2.61 $3.00 10 907 560
Feb 27, 2020 $2.85 $3.05 $2.55 $2.75 11 487 253
Feb 26, 2020 $2.39 $2.69 $2.26 $2.53 5 729 651
Feb 25, 2020 $2.45 $2.52 $2.26 $2.27 4 375 151
Feb 24, 2020 $2.63 $2.63 $2.32 $2.41 3 161 741
Feb 21, 2020 $2.73 $2.81 $2.54 $2.55 2 611 075
Feb 20, 2020 $2.76 $2.81 $2.70 $2.72 1 733 253
Feb 19, 2020 $2.95 $2.99 $2.74 $2.81 3 304 964
Feb 18, 2020 $2.80 $3.08 $2.80 $2.93 4 113 599
Feb 14, 2020 $2.85 $2.88 $2.76 $2.80 1 427 548
Feb 13, 2020 $2.95 $2.99 $2.81 $2.84 1 990 210
Feb 12, 2020 $2.89 $2.96 $2.86 $2.92 3 210 812
Feb 11, 2020 $2.95 $2.98 $2.86 $2.90 2 796 918
Feb 10, 2020 $2.89 $2.98 $2.85 $2.97 1 964 697
Feb 07, 2020 $2.94 $2.98 $2.85 $2.90 1 684 176
Feb 06, 2020 $3.04 $3.09 $2.86 $2.97 2 291 357
Feb 05, 2020 $3.07 $3.25 $3.03 $3.04 1 941 104
Feb 04, 2020 $3.17 $3.22 $2.99 $3.09 2 539 212
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT